First birth of domestic new drug seen this month

Published: 1999-06-03 17:32:00

Updated: 1999-06-03 17:32:00

The clinical phase II-b study for Sunpla 50mg inj. (SKI 2053R), a platinum complex anti-cancer drug developed by SK Pharmaceutical Co. was successfully completed and now submitted to the Central Pharmaceutical Evaluation Committee for study review on June 3.

If the Committee accepts its study,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK